Vertex Pharmaceuticals Inc (VRTX)

321.45
+0.43(+0.13%)
After Hours
320.72
-0.73(-0.23%)
- Real-time Data
  • Volume:
    1,279,968
  • Day's Range:
    319.58 - 323.67
  • 52 wk Range:
    225.28 - 324.75
Earnings results expected in 10 days

Vertex will announce its quarterly financial results in 10 days. Traders should take this into account as the share price often fluctuates around this time period.

VRTX Overview

Prev. Close
321.02
Day's Range
319.58-323.67
Revenue
6.63B
Open
321
52 wk Range
225.28-324.75
EPS
12.81
Volume
1,279,968
Market Cap
82.51B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,430,661
P/E Ratio
25.18
Beta
0.438
1-Year Change
41.68%
Shares Outstanding
256,691,452
Next Earnings Date
Feb 07, 2023
What is your sentiment on Vertex?
or
Market is currently closed. Voting is open during market hours.

Vertex Pharmaceuticals Inc News

Vertex Pharmaceuticals Inc Analysis

Vertex Pharmaceuticals Inc Company Profile

Vertex Pharmaceuticals Inc Company Profile

Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on developing medicines that treat the underlying cause of cystic fibrosis (CF) and it has several ongoing clinical and research programs to advance and extend treatment of CF. The Company's marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). Its four medicines are being used to treat the people with CF in North America, Europe and Australia. The Company has a pipeline of investigational therapies in other serious diseases where it is leveraging insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency, and muscular dystrophies. The Company’s other pipeline products include CTX001, VX-147, VX-121, VX-561, VX-548, and VX-880.

Read More

Analyst Price Target

Average329.16 (+2.40% Upside)
High440.00
Low280.00
Price321.45
No. of Analysts25
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellSellStrong BuyStrong BuyStrong Buy
SummaryStrong SellNeutralStrong BuyStrong BuyStrong Buy
  • Thank for the Vibe and offer VRTX! I like to earn $319.92 for I can invest in to stock really bad
    0
    • Kathy Wood is selling, time to load up long!
      0
      • Thanks for the ride VRTX!
        0
        • New moderna/ more shorts plz =))) --->295
          2
          • Keeps this stock, rotation from tech growth to value stock is coming this year, I expect VRTX will benefit from this.
            1
            • What a priceless tought. Safe money here in this actual cenario...
              0
          • this is a most unexpected though long awaited bump. glad i held
            0
            • finally, it's moving, I'm holding this one from more than a year
              0
              • it's so underpriced
                1
                • was there a stock split last 12 months?
                  2
                  • Nope?
                    0
                  • No
                    0
                • was there a stock split last 12 months?
                  1